Search Results - "Nyirjesy, Paul"

Refine Results
  1. 1

    Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes by Yano, Junko, Sobel, Jack D, Nyirjesy, Paul, Sobel, Ryan, Williams, Valerie L, Yu, Qingzhao, Noverr, Mairi C, Fidel, Jr, Paul L

    Published in BMC women's health (29-03-2019)
    “…Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are…”
    Get full text
    Journal Article
  2. 2

    Vulvovaginal Candidiasis and Bacterial Vaginosis by Nyirjesy, Paul, MD

    “…Vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV) are frequently encountered in clinical practice. Recent advances have furthered understanding of…”
    Get full text
    Journal Article
  3. 3

    Recurrent vulvovaginitis by Powell, Anna M., MD, Nyirjesy, Paul, MD

    “…Vulvovaginitis (VV) is one of the most commonly encountered problems by a gynecologist. Many women frequently self-treat with over-the-counter medications, and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Management of Persistent Vaginitis by Nyirjesy, Paul

    Published in Obstetrics and gynecology (New York. 1953) (01-12-2014)
    “…With vaginitis remaining a common condition that leads women to seek care, it is not surprising that some women develop chronic vulvovaginal problems that are…”
    Get full text
    Journal Article
  6. 6

    Candida glabrata complicating in vitro pregnancy: successful management of subsequent pregnancy by Asemota, Obehi A., M.D, Nyirjesy, Paul, M.D, Fox, Rachel, M.D, Sobel, Jack D., M.D

    Published in Fertility and sterility (01-02-2011)
    “…Objective To report the occurrence of Candida glabrata chorioamnionitis complicating an in vitro fertilization (IVF) pregnancy. Design Case report. Setting…”
    Get full text
    Journal Article
  7. 7

    Endometrial ablation devices: Review of a manufacturer and user facility device experience database by Della Badia, Carl, DO, Nyirjesy, Paul, MD, Atogho, Ata, MD

    Published in Journal of minimally invasive gynecology (01-07-2007)
    “…Our objective was to evaluate complications reported to the Manufacturer and User Facility Device Experience (MAUDE) database and to look for trends of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Management of Resistant Trichomoniasis by Alessio, Cynthia, Nyirjesy, Paul

    Published in Current infectious disease reports (01-09-2019)
    “…Purpose of Review Trichomonas vaginalis is the most prevalent sexually transmitted parasite in the USA; resistant infection is emerging. New drug therapies and…”
    Get full text
    Journal Article
  10. 10

    Fractionated CO2 Laser as Therapy in Recalcitrant Lichen Sclerosus by Balchander, Divya, Nyirjesy, Paul

    Published in Journal of lower genital tract disease (01-04-2020)
    “…The aim of this study was to evaluate the efficacy of the fractionated CO2 laser in treating recalcitrant lichen sclerosus (LS). The study population was 40…”
    Get full text
    Journal Article
  11. 11

    Hyaluronan in vaginal secretions: association with recurrent vulvovaginal candidiasis by Lev-Sagie, Ahinoam, MD, Nyirjesy, Paul, MD, Tarangelo, Nicholas, Bongiovanni, Ann Marie, BS, Bayer, Cynthia, CRNP, Linhares, Iara M., MD, Giraldo, Paulo C., MD, Ledger, William J., MD, Witkin, Steven S., PhD

    “…Objective We evaluated whether vaginal concentrations of hyaluronan were altered in women with recurrent vulvovaginal candidiasis (RVVC). Study Design Lavage…”
    Get full text
    Journal Article
  12. 12

    A Comparison of Newer and Traditional Approaches to Diagnosing Vaginal Infections by Powell, Anna, Goje, Oluwatosin, Nyirjesy, Paul

    Published in Obstetrics and gynecology (New York. 1953) (01-04-2024)
    “…Molecular diagnostic testing (eg, polymerase chain reaction [PCR]-based vaginitis testing) is widely used in clinical practice, although vaginitis experts have…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis by Sobel, Jack D, Nyirjesy, Paul

    Published in Future microbiology (01-12-2021)
    “…Recurrent vulvovaginal candidiasis (RVVC) has significant disease, financial and quality-of-life burdens, affects women from all strata of society worldwide,…”
    Get full text
    Journal Article
  15. 15

    Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines by Nyirjesy, Paul, Brookhart, Carolyn, Lazenby, Gweneth, Schwebke, Jane, Sobel, Jack D

    Published in Clinical infectious diseases (13-04-2022)
    “…Abstract Background Vulvovaginal candidiasis (VVC) is a common cause of vulvovaginal itching and discharge. This article discusses the latest CDC STI Treatment…”
    Get full text
    Journal Article
  16. 16

    Vaginal Candida parapsilosis: pathogen or bystander? by Nyirjesy, Paul, Alexander, Alynn B, Weitz, M Velma

    “…OBJECTIVE: Candida parapsilosis is an infrequent isolate on vaginal cultures; its role as a vaginal pathogen remains unstudied. This retrospective study of…”
    Get full text
    Journal Article
  17. 17

    Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor by Nyirjesy, Paul, Zhao, Yue, Ways, Kirk, Usiskin, Keith

    Published in Current medical research and opinion (01-07-2012)
    “…Abstract Background/objective: Women with type 2 diabetes mellitus (T2DM) are at increased risk for vaginal Candida colonization, perhaps because of…”
    Get full text
    Journal Article
  18. 18

    Metronidazole-Resistant Trichomoniasis: Beneficial Pharmacodynamic Relationship With High-Dose Oral Tinidazole and Vaginal Paromomycin Combination Therapy by Henien, Mira, Nyirjesy, Paul, Smith, Katharine

    Published in Sexually transmitted diseases (01-01-2019)
    “…ABSTRACTMetronidazole-resistant trichomoniasis is an uncommon condition that presents significant therapeutic challenges. Combination therapy with high-dose…”
    Get full text
    Journal Article
  19. 19

    Vaginitis and risk of sexually transmitted infections: results of a multi-center U.S. clinical study using STI nucleic acid amplification testing by Schwebke, Jane R, Nyirjesy, Paul, Dsouza, Melissa, Getman, Damon

    Published in Journal of clinical microbiology (11-09-2024)
    “…Significant increases in rates of sexually transmitted infections (STIs) caused by (TV), (CT), (NG), and (MG) are occurring in the United States. We present…”
    Get more information
    Journal Article
  20. 20

    Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment by Nyirjesy, Paul, Schwebke, Jane R

    Published in Future microbiology (01-04-2018)
    “…Secnidazole is a next-generation 5-nitroimidazole approved for more than three decades in Europe, Asia, South America and Africa and recently in the USA as a…”
    Get full text
    Journal Article